Luo et al. confirmed that lncRNA RP11-89 competes endogenously to regulate ferroptosis and BLCA progression via the RP11-89/miR-129-5p/PROM2 axis and may modulate the immune microenvironment through PROM234. Here, PROM2 is linked to bladder transitional cell carcinoma.